ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

FHI vs CNS // EV/EBITDA & P/E VALUATION

Federated Hermes Inc. (NYSE) VS. Cohen & Steers Inc (NYSE) • 15-METRIC TALLY: FHI 7 — CNS 1
▲ EV/EBITDA & P/E VALUATION LEADER: FHI
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (FHI VS. CNS) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC FHI CNS SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) 39.80% 33.70% +6.10 FHI /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE 8.0x 19.7x -11.70 FHI /valuation <GO>
Free Cash Flow Yield 6.80% -3.37% +10.17 FHI /fcf-yield <GO>
Operating Margin 28.50% — — TIE /operating-margins <GO>
Net Profit Margin 22.40% — — TIE /net-margins <GO>
Revenue Growth (YoY) 10.30% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 2.42% 3.39% -0.97 CNS /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 8/9 2/9 +6.00 FHI /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 55.0 52.1 +2.90 FHI /rsi-technicals <GO>
10Y Yield & FRED Macro Beta 1.03 — — TIE /macro-sensitivity <GO>
Forward P/E Multiple 10.0x 22.8x -12.80 FHI /forward-pe <GO>
Enterprise Scale & Market Cap $4.33B $3.75B $581.9M FHI /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR FHI REV CNS REV FHI GROSS % CNS GROSS % FHI FCF CNS FCF
FY 2025 $1.80B $0 — — $294.6M -$126.4M
FY 2024 $1.63B $0 — — $342.5M $85.0M
FY 2023 $1.61B $0 — — $239.4M $172.0M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
FHI // BETA 1.03
CNS // BETA —